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Abstract
Objective Many patients with symptomatic cholelithiasis report persisting symptoms after elective cholecystectomy. The
current prospective follow-up study aims at the identification and valuation of risk factors for negative symptomatic
outcome at 6 weeks.
Methods Consecutive patients (n=183), age 18–65 years, indicated for elective cholecystectomy due to symptomatic
cholelithiasis, completed a self-report questionnaire. At 6 weeks post-operatively, the same self-report questionnaires were
completed (n=129). Predictors of the persistence and emergence of biliary and dyspeptic symptoms at 6 weeks post-
cholecystectomy were investigated using univariate and multivariate logistic regression.
Results At 6 weeks post-operatively, the report of post-operative biliary symptoms was independently predicted by pre-
operative dyspeptic symptoms (OR=6.60) and bad taste (OR=3.55). Pre-operative flatulence was an independent predictor
of the report of biliary and dyspeptic symptoms ((OR=3.33) and (OR=3.27), respectively) and persisting biliary symptoms
(OR=4.21). Predictors of symptomatic outcome were only identified in women, not in men.
Conclusion Patients with pre-operative dyspeptic symptoms, notably bad taste and flatulence, have an increased risk of
negative post-cholecystectomy outcomes at 6 weeks. A symptom-specific approach should lead to optimalization of the
indication of cholecystectomy and information of patients. Known risk factors for long-term outcomes might be valuable in
female patients only.
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Gallstone disease (cholelithiasis) is a common condition in the
Western world. In the Netherlands, 32,000 patients are yearly
diagnosed with this condition.1 The majority of patients
remains asymptomatic and only 20% of patients develop
clinical symptoms.2–4 Symptomatic gallstone disease is
typically diagnosed after an episode of biliary pain, which
is defined as a severe steady pain, lasting more than 15–
30 min, usually located in the epigastrum and/or right upper
quadrant, sometimes radiating to the back,2,5 which is often
accompanied by dyspeptic symptoms.6–9 However, some
patients experience mild dyspeptic symptoms without biliary
colics.10 Additional ultrasonography is recommended,2,9,11
as clinical symptoms are not consistently related to the
presence of gallstones.11–14 Professional guidelines propose
conservative treatment (wait and see) in asymptomatic
cholelithiasis2,9,15 and cholecystectomy in symptomatic
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cholelithiasis. In biliary pain without stones, cholecystecto-
my is occasionally indicated10 following additional surgical
consultation.2
Elective cholecystectomy is widely performed in 70% of
the symptomatic patients.16 In the Netherlands, cholecys-
tectomy is performed in 19,000 patients a year.1 The
majority of patients report positive outcomes and relief
rates for biliary pain (86–96%), upper abdominal pain (66–
77%), and dyspepsia (46–89%)13 are high. However, a
substantial group of patients report persistence of pre-
existent biliary (5.5–19.5%) and dyspeptic symptoms
(27.3–43.2%).8,17,18 Thus, recognition of patients with a
high risk of negative outcomes is crucial.
In literature, pre-operative dyspeptic symptoms, the use
of psychotropic medication, and a long history of pain,
symptoms, and biliary attacks are mentioned as potential
predictors of poor outcome and persisting pain17–19 at
6 months post-cholecystectomy. Although clinical experi-
ence indicates that most patients experience a major
reduction of symptoms at 6 weeks post-cholecystectomy,20
no studies have explored predictors of symptomatic
outcome at this time point. The present prospective
follow-up study aims at the identification and the valuation




Between March 2006 and August 2007, all patients
between 18 and 65 years with diagnosed cholelithiasis
(diagnosis K80 from International Statistical Classification
of Diseases and Related Health Problems (ICD-10)),
awaiting an elective laparoscopic cholecystectomy at the
department of Surgery of the St. Elisabeth Hospital in
Tilburg, the Netherlands, were eligible for the study.
Exclusion criteria were: patients with ASA III or IV,
undergoing an emergency procedure or intended open
cholecystectomy, insufficient knowledge of the Dutch
language, choledocholithiasis, cholangitis, known pregnan-
cy, known liver cirrhosis, history of abdominal malignancy,
previous upper abdominal surgery (precluding laparoscopic
approach), and psychiatric diseases.
Procedure
During patients’ visit to the outpatient clinic, the surgeon
performed a physical examination and explained the
surgical and anesthetic procedures. Patients were informed
about the general prognosis after cholecystectomy and the
risk of complications. Furthermore, the surgeon introduced
the study and asked the patients to participate. Nurses
informed patients further about the operation and the study,
and handed out written information and the first set of
questionnaires. Patients read the information at home and
signed informed consent before participation. Pre-opera-
tively, records were checked for medical history, comor-
bidity, and medication use. Before admission for
cholecystectomy, patients completed the first question-
naires, which could be returned by mail or delivered to
the nurses at the ward. In case the questionnaires were not
returned 5 to 3 days before surgery, patients received a
telephone call to remind them to complete the question-
naire. Patients who returned their first set of questionnaires
after surgery were excluded from the study.
Six weeks after surgery, patients were sent another self-
report questionnaire. Eight weeks and 10 weeks after
surgery, a phone call reminded the patients to return the
post-operative questionnaire to the hospital, if necessary.
The protocol of the study was approved by the local ethics
committee.
Questionnaires and Medical Files
Questionnaires comprised self-reported demographic and
clinical information. The demographic questionnaire asked
about sex, age, marital status, educational level, and work.
Furthermore, patients completed a self-constructed symp-
tom checklist, which asked about the presence of symptoms
in the past week. Symptoms were collected from biliary
patients participating in focus groups. Following a study of
Weinert et al.,17 symptoms were categorized into symptom
complexes, namely biliary symptoms (upper abdominal
pain, nausea, vomiting), dyspeptic symptoms (bad taste,
heartburn, under abdominal pain, diarrhea, and flatulence),
and non-specific symptoms (general malaise, fatigue,
weight change, decrease in sexual functioning, and other
health complaints not mentioned in the checklist). Medical
files were checked for the experience of biliary and
dyspeptic symptoms ever before visiting the outpatient
clinic. After surgery, surgical reports were checked for the
presence of gallstones/sludge and conversion to open
surgery.
Surgical and Anesthetic Procedure
Open introduction was performed in all patients regardless
of previous abdominal surgery. Pneumoperitoneum was
created using the subumbilical trocar with an intra-
abdominal pressure up to 12 mmHg. Three trocars for
instruments were inserted. The dissection of the cystic
artery and cystic duct, identifying Calot’s triangle, was
performed using a three-point ‘flag’ technique. The cystic
duct and artery were clipped and transsected. After
J Gastrointest Surg (2009) 13:304–311 305
complete dissection of the gallbladder, it was removed
either through the subumbilical or subxyphoidal trocar.
Fascia defects as a result of the insertion of the 10 mm
trocar and the open introduction of the subumbilical trocar
were closed. No suction drains were left in the subhepatic
space at the end of the procedure.
In principle, all patients were subjected to a standard
anesthetic regime. As premedication, patients received para-
cetamol 1,000 mg supp. and atropine 0.5 mg i.m. Patients
<60 years and >60 kg received diazepam 10 mg. p.o.; patients
>60 years and <60 kg received diazepam 5 mg. p.o. Peri-
operative anesthesia consists of propofol 1.5–2.5 mg/kg,
sufenta 0.25 μg/kg, and rocuronium 0.6 mg/kg. Standard
post-operative analgetics were paracetamol 4 dd 1,000 mg
supp. and morphine 6 dd 10 mg s during the first 48 h
post-operatively, until patients’ indicated pain was accept-
able. If necessary, patients received additional diclofenac
2 dd 100 mg supp.
Statistical Analyses
Pre-operative differences between responders (patients who
returned their questionnaires at 6 weeks) vs. non-responders
and dropouts (patients who ended participation within
6 weeks) were investigated by chi-square tests (using
Fisher’s exact test when appropriate) and Student’s t tests.
Changes in symptoms were examined by the McNemar
test. Analyses were performed both for specific symptoms
and symptom complexes.
Furthermore, persistence and emergence rates were
calculated. Therefore, the population under study was
divided in two subgroups categorized by the presence
(group 1) or absence (group 2) of self-reported pre-
operative biliary or dyspeptic symptoms. Patients with
pre-operative biliary symptoms (group 1) reported biliary
symptoms only or both biliary and dyspeptic symptoms.
Patients without pre-operative biliary symptoms (group 2)
suffered from dyspeptic symptoms only. Likewise, patients
with and without pre-operative dyspeptic symptoms were
categorized into two groups. Persistence was defined as
reporting the symptoms both before and after cholecystec-
tomy. Emergence was defined as not reporting the
symptoms pre-operatively, but reporting the symptoms at
6 weeks post-cholecystectomy.
To discern which pre-operative symptoms predicted the
post-operative report, the persistence, and the emergence
of post-operative symptoms, we used univariate logistic
regression. Furthermore, significant univariate predictors
of each outcome were entered in a multivariate regression
model (method enter) to assess the relative strength of
each predictor. In both outcome and predictors, we
differentiated between symptom complexes and specific
symptoms.
A p value <.050 indicated statistical significance.




Figure 1 provides an overview of the population across
time. Of all 241 patients visiting the outpatient clinic and
being approached for participation, 211 received the first
questionnaire. Statistical analyses were performed on 183
patients (response rate 86.7%). Within 6 weeks, five
patients ended participation. Six weeks after cholecystecto-
my, data were available from 129 patients (response rate
70.5%). Because of missing values, final statistical analyses
were performed on 126 patients. In 94.0% of the patients,
biliary stones or sludge were demonstrated by ultrasonic
tomography. Pre-operatively, endoscopic sphincterotomy
had been performed in eight patients. Laparoscopic chole-
cystectomy was converted to an open procedure in six
patients. Table 1 shows the demographic and clinical
characteristics of the patient group. Pre-operatively, partic-
ipants in the study did not differ from non-responders and
patients who ended participation within 6 weeks. Among
the participants, 74.3% were females and the mean age was
46.0±11.4 years. Female patients were younger than male
Pre-operatively 
Total number of patients approached  
Expectative management  
Refused participation  
Received the pre-operative questionnaires 
Not returned pre-operative questionnaires  
Population pre-operatively  
Ended participation within six weeks 
post-operatively 
Six weeks post-cholecystectomy  
Received questionnaires at six weeks 
Not returned questionnaires at six weeks 
Population post-operatively  
N = 241 
N = 17 
N = 211 
N = 13 
N = 28 
N = 183 
N = 5 
N = 178 
N = 49   
N = 129  
Figure 1 Flow chart of the population in the course of 6 weeks.
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patients (50.7±9.6 years vs. 44.5±11.6 years; (t=3.30,
p=.001)). Male patients more often reported urogenital
diseases (p=.034) than female patients.
Pre-operative Symptoms
In the week before visiting the outpatient clinic, 73.6% of
the patients experienced biliary symptoms and 66.7% of the
patients experienced dyspeptic symptoms (Table 1). Fur-
thermore, 14.3% of all patients (n=27) did not report any
biliary or dyspeptic symptoms. In the week before surgical
consultation, female patients reported more pre-operative
biliary symptoms than male patients (78.5% vs. 59.6%,
p=.019), whereas male patients more often reported to be
free of symptoms than female patients (25.5% vs. 10.4%,
p=.021). Moreover, examination of medical files revealed
that 84.7% and 73.2% of the patients had ever experienced
biliary and dyspeptic symptoms. More specifically, 26.8%
had experienced only biliary symptoms, 15.3% had
experienced only dyspeptic symptoms, whereas 57.9% of
the patients had ever experienced both biliary and dyspeptic
symptoms. Patients reported a mean of 5.5±7.7 biliary
attacks. Pre-operatively, upper abdominal pain was most
frequently reported (66.5%), followed by nausea (39.3%)
and flatulence (36.1%). Moreover, 55.2% of all patients
reported non-specific symptoms. Female patients more
often reported bad taste (χ2=5.27, p=.022), upper abdom-
inal pain (χ2=4.25, p=.039), nausea (χ2=9.70; p=.002),
diarrhea (χ2=4.80, p=.029), and non-specific symptoms
(χ2=6.41, p=.011) than male patients.
Course of Symptoms
In the time between the pre-operative measurement and
6 weeks after cholecystectomy, five patients received an
endoscopic sphincterotomy, of which two patients already
received this procedure pre-operatively. Furthermore, a
general improvement was observed. The number of patients
reporting biliary and dyspeptic symptoms reduced to 25.4%
and 50.8%, respectively (χ2=47.38, p<.001 and χ2=5.56,
p=.018). More specifically, the number of patients report-
ing bad taste, heartburn, upper abdominal pain, nausea,
vomiting, and under abdominal pain reduced significantly
over 6 weeks’ time (see Table 2). The percentage of
patients reporting to be free of symptoms increased to
44.4% (χ2=47.38, p<.001) (see Fig. 2).
In spite of the general improvements over 6 weeks’ time,
biliary symptoms persisted in 27.8% of the patients with
pre-operative biliary symptoms, whereas biliary symptoms
emerged in 17.1% of the patients with only pre-operative
dyspeptic symptoms. Persistence of dyspeptic symptoms
was reported in 57.3% of the patients biliary, dyspeptic, and




Female patients (%) 74.3
Age (M±SD) 46.0±11.4
Highest level of education
Primary and/or lower vocational education (%) 20.6
Secondary education (%) 45.6
Higher education (%) 6.1
Higher professional education or university (%) 27.8
Working under payment (%) 72.4
Marital status
Single (%) 6.1
Widowed or divorced (%) 6.6
Married or cohabitant (%) 87.3
Comorbidities
Coronary arterial diseases (%) 20.3
Pneumonal diseases (%) 7.4
Abdominal diseases (%) 25.0
Kidney diseases (%) 2.0
Urogenital diseases (%) 9.5
Neurological diseases (%) 11.5
Rest category of comorbidities (%) 48.0
Self-reported medication use
Analgesics (%) 37.8
Psychotropic medication (%) 10.1




Free of symptoms (%) 14.3
Frequency of biliary colics (M±SD) 5.47±7.68
Demonstrated gallstones (%) 94.0
Pre-operative symptoms ≤6 months (%) 68.3
Pre-operative symptoms ≥7 months (%) 31.3








Bad taste (%) 24.0 12.7 .001*
Heartburn (%) 25.1 15.1 .015*
Upper abdominal pain (%) 66.5 19.8 <.001*
Nausea (%) 39.3 13.5 <.001*
Vomiting (%) 14.8 3.2 .001*
Under abdominal pain (%) 24.6 8.7 .003*
Diarrhea (%) 18.0 13.5 .839




McNemar tests were used to analyze changes in symptoms over time
*Significance p<.050
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non-specific symptoms. At 6 weeks, dyspeptic symptoms
emerged in 38.6% of the patients who reported pre-
operative biliary symptoms only.
Symptom- and Sex-specific Patterns of the Course
of Symptoms
At 6 weeks post-cholecystectomy, patients with and without
demonstrated biliary stones and/or sludge reported post-
operative biliary and dyspeptic symptoms to the same
extent. Subgroups of patients with and without pre-
operative biliary symptoms experienced post-operative
dyspeptic symptoms to the same extent (45.7% and
52.2%, respectively). Furthermore, patients with pre-oper-
ative dyspeptic symptoms reported post-operative biliary
symptoms more often than patients without pre-operative
dyspeptic symptoms (35.4% vs. 6.8%; χ2=10.86, p=.001).
Stratifying the self-reported improvements at 6 weeks
post-cholecystectomy by sex, a different pattern of change
was observed for male and female patients (see Fig. 3).
Furthermore, no sex-bound patterns were found with regard
to the emergence and persistence of biliary and dyspeptic
symptoms after cholecystectomy.
Pre-operative Symptoms in the Prediction of Symptomatic
Outcome
Univariate logistic regression analyses were used to identify
the predictors of post-operative biliary and dyspeptic
symptoms, and the persistence and emergence of biliary
and dyspeptic symptoms (see Table 3). Duration of pre-
operative symptoms and pre-operative medication use were
not significant predictors. No univariate predictors could be
distinguished for the emergence of dyspeptic symptoms at
6 weeks.
The differential value of the identified predictors was
further explored in multivariate logistic regression analyses,
inserting the univariate predictors for each outcome as
variables (method enter). The report of biliary symptoms at
6 weeks post-operatively was independently predicted by
pre-operative dyspeptic symptoms, bad taste, and flatulence
(see Table 4). Both the report of post-operative dyspeptic
symptoms and the persistence of biliary symptoms were
independently predicted by pre-operative flatulence. Other
univariate predictors of post-operative symptomatic out-
comes were non-significant.
Eligibility of Pre-operative Symptoms in the Prediction
Symptomatic Outcome
First of all, sex-specific predictors were investigated by
univariate logistic regression analysis (Table 5). Predictors
of the post-operative report and the persistence of biliary
and dyspeptic symptoms were identified in female patients
only, and not in male patients. In both men and women, no
predictors were distinguished for the development of biliary
and dyspeptic symptoms. Moreover, the univariate predic-
tors of each outcome were simultaneously entered in
multivariate logistic regression analyses. These analyses
could only be performed on the population of female
patients. In female patients, the post-operative experience
of biliary symptoms was independently predicted by bad
taste only (OR=3.73, p=.008; 95% CI 1.42–9.84). At
6 weeks, the report of dyspeptic symptoms was predicted
Figure 2 Report of symptoms in the total population.
Figure 3 Course of symptoms over 6 weeks’ time.
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by heartburn and flatulence (OR=2.70, p=.040; 95% CI
1.04–6.96 and OR=2.91, p=.020; 95% CI 1.19–7.13,
respectively). For the prediction of persisting biliary
symptoms, no independent predictors could be identified.
Discussion
Most people with gallbladder stones never become patients,
as they remain asymptomatic. Elective cholecystectomy is
performed in 70% of patients with symptomatic cholelithi-
asis16 aiming at a release from pain and symptoms and
preventing complications. Post-operatively, a significant
group of patients report persisting symptoms.17–19,21–23
Furthermore, cholecystectomy entails the risk of common
bile duct injury and mortality in 0.5% and 0.2% of the
patients, respectively.24 Therefore, performance of elective
cholecystectomy should be considered critically and recog-
nition of patients with a high risk of negative outcomes is
crucial. In this prospective follow-up study, we investigated
the role of pre-operative symptoms in the prediction of
negative symptomatic outcome. The results of this study
show that pre-operative dyspeptic symptoms, or more
specifically bad taste and flatulence, are independent
predictors for the experience of biliary and dyspeptic
symptoms and the persistence of biliary symptoms. Al-
though sex does not predict post-operative outcome,
predictors are only identified in female patients.
In the current study, all abdominal symptoms decrease
after cholecystectomy (with the exception of diarrhea),
which is also reported in studies with follow-up at
6 months17,25 or more than 1 year.23,26 In line with other
studies,13,17 greatest improvement was found for biliary
symptoms, whereas dyspeptic symptoms more often per-
sisted and emerged. At 6 months after cholecystectomy or
later, biliary symptoms are found to be persistent in 5.6–
20.0% of the patients17 and dyspeptic symptoms are
persistent in 10.0–40.2% of the patients.17,23,27 In the
current study, we found higher percentages of 27.8% and
57.3% for persistent biliary and dyspeptic symptoms, which
may be attributed to the timeframe of 6 weeks before
follow-up. Approximately one third of the patients with
biliary or dyspeptic symptoms only developed another type
of symptoms at 6 weeks post-operatively. Although one
Table 3 Univariate Predictors of Post-operative Symptoms at 6 Weeks (Total Population)
Post-operative outcome Pre-operative predictor OR 95% CI p
Report of biliary symptoms Dyspeptic symptoms 7.48 2.13–26.27 .002*
Sex 4.10 1.15–14.58 .029*
Bad taste 4.00 1.67–9.55 .002*
Heartburn 2.38 1.01–5.60 .047*
Nausea 2.38 1.05–5.38 .038*
Flatulence 3.36 1.46–7.73 .004*
Report of dyspeptic symptoms Dyspeptic symptoms 2.13 1.01–4.51 .047*
Heartburn 2.60 1.14–5.95 .024*
Flatulence 3.54 1.62–7.75 .002*
Persistent biliary symptoms Dyspeptic symptoms 6.73 1.46–31.09 .015*
Bad taste 3.69 1.37–9.96 .010*
Flatulence 2.83 1.09–7.35 .033*
Emergent biliary symptoms Flatulence 13.13 1.32–130.24 .028*
Persistent dyspeptic symptoms Flatulence 3.28 1.32–8.17 .011*
Univariate logistic regression analysis was used to investigate the prediction of post-operative outcomes at 6 weeks post-cholecystectomy
*Significance p<.050
Table 4 Differential Value of Predictors of Post-operative Symptomatic Outcome (Total Population)
Post-operative outcome Pre-operative predictor OR 95% CI p
Report of biliary symptoms Dyspeptic symptoms 6.60 1.86–23.45 .005*
Bad taste 3.55 1.38–9.17 .009*
Flatulence 3.33 1.48–7.26 .004*
Report of dyspeptic symptoms Flatulence 3.27 1.48–7.26 .004*
Persistent biliary symptoms Flatulence 4.21 1.46–12.19 .008*
Multivariate logistic regression analysis was used to investigate the prediction of post-operative outcomes at 6 weeks post-cholecystectomy
*Significance p<.050
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study17 reports a one-directional shift from pre-operative
biliary to post-operative dyspeptic symptoms, the findings
from the current study suggest a bidirectional shift from
pre-operative biliary symptoms to post-operative dyspeptic
symptoms and vice versa.
As cholecystectomy is not beneficial to all patients,
distinguishing patients with a heightened risk of persisting
and emerging symptoms at 6 weeks is important. Literature
mentions pre-operative dyspeptic symptoms, pre-operative
flatulence, and experiencing over three symptoms of
flatulent dyspepsia as predictors of negative post-cholecys-
tectomy outcomes, such as post-cholecystectomy syndrome
and persistence of a bothersome symptom.17,25,28 In
addition, the current study asserts that pre-operative
dyspeptic symptoms, bad taste, and flatulence are associat-
ed with a three to seven times greater risk of post-operative
biliary and dyspeptic symptoms. Furthermore, pre-operative
flatulence is associated with a four times greater risk of
persisting biliary symptoms after cholecystectomy. Aware-
ness of these risk factors might have strong implications for
clinical practice. Surgeons should be alert on the recogni-
tion of these patients during anamnesis and patients should
be informed about their symptom-specific risk of negative
post-cholecystectomy outcome. Furthermore, the existing
knowledge on risk factors for negative symptomatic
outcome should be integrated in clinical decision making,
with regard to guidelines for the indication of cholecystec-
tomy and consideration of alternative treatment options.
Sex has an ambiguous position as a predictor of post-
cholecystectomy symptomatic outcome. Although male sex
is found to be a predictor of a ‘not very successful’
outcome17 in literature, the current study indicates that sex
is no predictor of self-reported symptoms or the persistence
or emergence of these symptoms. However, predictors are
only identifiable in female patients and not in male patients.
The latter point has implications for knowledge from the
existing literature on predictors of post-cholecystectomy
outcome. As the bulk of studies do not differentiate
between male and female patients, we recommend a careful
interpretation of results and the inclusion of the variable
‘sex’ in the design of future studies on cholecystectomy.
This study has several limitations. As this is a single-
institution study, generalization of the results to other health
care centers might be limited. We investigated the predictive
value of pre-operative symptoms, taking biliary or dyspeptic
symptoms as feature of a clinical representation of cholelithi-
asis. Coinciding with biliary stones, dyspeptic symptoms are
easily interpreted as a clinical feature of cholelithiasis.
However, dyspeptic symptoms are quite common in the
general population and may still be an isolated condition, even
in the context of biliary stones. Therefore, although our results
imply a relation between dyspeptic symptoms and post-
operative outcome at 6 weeks, results should be interpreted
with care. Unfortunately, we did not specifically investigate
the combination of both biliary and dyspeptic symptoms or
the interaction between biliary and dyspeptic symptoms on the
prediction of 6 weeks symptomatic outcome. We recommend
that this issue will be addressed in future research. Further-
more, this study investigated pre-operative symptoms as
predictors of negative symptomatic outcome at 6 weeks
post-cholecystectomy. Future studies should investigate the
relation between symptomatic outcome at 6 weeks and long-
term outcomes, or the post-cholecystectomy syndrome.
Despite the small sample of male patients (n=46), we found
a sex difference in terms of the impossibility to identify
predictors of negative symptomatic outcome in male
patients, in contrast to several predictors in female patients.
Extensive exploration of predictors should be aimed at a
bigger sample of male patients and studies on predictors of
long-term post-cholecystectomy outcomes should integrate
sex as a potential variable. Another shortcoming in this study
is the fact that symptomatic outcome is a one-dimensional
outcome, indicating the presence of symptoms only. Within
this measure, differentiation should be sought by investigat-
ing severity and duration, implications for all day living, and
psychosocial consequences.
In summary, at 6 weeks post-cholecystectomy, 27.8% and
57.3% of the patients reported the persistence of pre-operative
Table 5 Univariate Predictors of the Report of Post-operative Symptoms at 6 Weeks (Female Patients)
Post-operative outcome Pre-operative predictor OR 95% CI p
Report of biliary symptoms Dyspeptic symptoms 5.29 1.45–19.28 .012*
Bad taste 3.81 1.48–9.82 .006*
Under abdominal pain 2.75 1.04–7.30 .042*
Report of dyspeptic symptoms Heartburn 2.90 1.15–7.28 .024*
Flatulence 3.09 1.29–7.43 .012*
Persistent biliary symptoms Heartburn 2.94 1.08–8.05 .036*
Flatulence 2.94 1.08–8.05 .036*
Persistent dyspeptic symptoms Flatulence 3.15 1.15–8.60 .025*
Univariate logistic regression analysis was used to investigate the prediction of post-operative outcomes at 6 weeks post-cholecystectomy
*Significance p<.050
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biliary and dyspeptic symptoms, respectively. Furthermore,
17.1% and 38.6% of the patients with only dyspeptic or only
biliary symptoms developed another type of symptoms after
cholecystectomy. Sex is no predictor of post-operative out-
come, whereas pre-operative symptomatology is. Patients
reporting pre-operative dyspeptic symptoms, bad taste, or
flatulence have a heightened risk of experiencing post-
operative biliary symptoms. Besides, patients with pre-opera-
tive flatulence are at risk for the experience of post-operative
dyspeptic symptoms and the persistence of pre-existing biliary
symptoms. Management of cholelithiasis should be patient
tailored, thereby considering the prognosis after cholecystec-
tomy differentially, based on the clinical presentation of pre-
operative symptoms. So far, predictors of post-operative
symptomatic outcome have only been identified in female
patients and not in male patients.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Prismant: Landelijke LRM-informatie, 2005. http://www.prismant.
nl/informatie-expertise/Thema’s/zienkenhuisstatistieken.
2. SSAT patient care guidelines. Treatment of gallstone and
gallbladder disease. J Gastrointest Surg 2007;11:1222–1224.
doi:10.1007/s11605-007-0202-3.
3. Jacoby I, Scott TE. NIH Consensus Conference on laparoscopic
cholecystectomy: are reforms necessary. JAMA 1993;270:320–
321. doi:10.1001/jama.270.3.320.
4. Halldestam I, Enell LE, Kullman E, Borch K. Development of
symptoms and complications in individuals with asymptomatic
gallstones. Br J Surg 2004;91:734–738. doi:10.1002/bjs.4547.
5. Schoenfield LJCN, Dowling RH et al. Asymptomatic gallstones.
Definition and treatment. Rom88 working team report no 5.
Gastroenterol Int 1988;1:17–28.
6. Diehl AK. Symptoms of gallstone disease. Baillieres Clin Gastro-
enterol 1992;6:635–657. doi:10.1016/0950-3528(92)90044-F.
7. Kellow JE. Organic causes of dyspepsia, and discriminating
functional from organic dyspepsia. Baillieres Clin Gastroenterol
1998;12:477–487. doi:10.1016/S0950-3528(98)90019-7.
8. Abu Farsakh NA, Stietieh M, Abu Farsakh FA. The postchole-
cystectomy syndrome. A role for duodenogastric reflux. J Clin
Gastroenterol 1996;22:197–201. doi:10.1097/00004836-
199604000-00009.
9. NVVH, ed. Evidence Based Richtlijn. Onderzoek en behandeling
van galstenen. Utrecht: NVVH, 2007.
10. Treatment of gallstone and gallbladder disease. SSAT patient care
guidelines. J Gastrointest Surg. 2004;8:363–4. doi:10.1016/j.
gassur.2003.11.025.
11. Diehl AK, Sugarek NJ, Todd KH. Clinical evaluation for gallstone
disease: usefulness of symptoms and signs in diagnosis. Am J
Med 1990;89:29–33. doi:10.1016/0002-9343(90)90094-T.
12. Kraag N, Thijs C, Knipschild P. Dyspepsia—how noisy are
gallstones? A meta-analysis of epidemiologic studies of biliary
pain, dyspeptic symptoms, and food intolerance. Scand J Gastro-
enterol 1995;30:411–421. doi:10.3109/00365529509093300.
13. Berger MY, Olde Hartman TC, Bohnen AM. Abdominal
symptoms: do they disappear after cholecystectomy. Surg Endosc
2003;17:1723–1728. doi:10.1007/s00464-002-9154-6.
14. Berger MY, Olde Hartman TC, van der Velden JJIM, Bohnen AM.
Is biliary pain exclusively related to gallbladder stones? A
controlled prospective study. Br J Gen Pract 2004;54:574–579.
15. Aerts R, Penninckx F. The burden of gallstone disease in Europe.
Aliment Pharmacol Ther 2003;18(Suppl 3):49–53. doi:10.1046/
j.0953-0673.2003.01721.x.
16. Keulemans YC, Venneman NG, Gouma DJ, van Berge
Henegouwen GP. New strategies for the treatment of gallstone
disease. Scand J Gastroenterol Suppl 2002;236:87–90. doi:10.1080/
003655202320621526.
17. Weinert CRAD, Jacobs D, Kane R. Relationship between
persistence of abdominal symptoms and successful outcome after
cholecystectomy. Arch Intern Med 2000;160:989–995.
doi:10.1001/archinte.160.7.989.
18. Luman W, Adams WH, Nixon SN, McIntyre IM, Hamer-Hodges
D, Wilson G et al. Incidence of persistent symptoms after
laparoscopic cholecystectomy: a prospective study. Gut
1996;39:863–866. doi:10.1136/gut.39.6.863.
19. Borly L, Anderson IB, Bardram L, Christensen E, Sehested A,
Kehlet H et al. Preoperative prediction model of outcome after
cholecystectomy for symptomatic gallstones. Scand J Gastro-
enterol 1999;34:1144–1152. doi:10.1080/003655299750024968.
20. Donceel P, Du Bois M. Fitness for work after laparoscopic and
open cholecystectomy. Acta Chir Belg 1997;97:168–172.
21. Bisgaard T, Rosenberg J, Kehlet H. From acute to chronic pain after
laparoscopic cholecystectomy: a prospective follow-up analysis.
Scand J Gastroenterol 2005;40:1358–1364. doi:10.1080/
00365520510023675.
22. Lublin MCD, Hiatt JR, Phillips EH. Symptoms before and after
laparoscopic cholecystectomy for gallstones. Am Surg
2004;70:863–866.
23. Ross E, Zambon DG. Postcholecystectomy symptoms. A pro-
spective study of gall stone patients before and two years after
surgery. Gut 1987;28:1500–1504. doi:10.1136/gut.28.11.1500.
24. Shea JA, Healey MJ, Berlin JA, Clarke JR, Malet PF, Staroscik
RN et al. Mortality and complications associated with laparoscop-
ic cholecystectomy. A meta-analysis. Ann Surg 1996;224:609–
620. doi:10.1097/00000658-199611000-00005.
25. McMahon AJ, Ross S, Baxter JN, Russell IT, Anderson JR,
Morran CG et al. Symptomatic outcome 1 year after laparo-
scopic and minilaparotomy cholecystectomy: a randomized
trial. Br J Surg 1995;82:1378–1382. doi:10.1002/bjs.18008
21028.
26. Finan KR, Leeth RR, Whitley BM, Klapow JC, Hawn MT.
Improvement in gastrointestinal symptoms and quality of life after
cholecystectomy. Am J Surg 2006;192:196–202. doi:10.1016/j.
amjsurg.2006.01.020.
27. Russello D, Di Stefano A, Scala R, Favetta A, Emmi S, Guastella
T, Latteri F. Does cholecystectomy always resolve biliary disease.
Minerva Chir 1997;52:1435–1439.
28. Bateson MC. Fortnightly review: gallbladder disease. BMJ
1999;318:1745–1748.
J Gastrointest Surg (2009) 13:304–311 311
